191 related articles for article (PubMed ID: 23659360)
1. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
Ramtvedt BE; Røinås E; Aabech HS; Sundet KS
J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):597-604. PubMed ID: 23659360
[TBL] [Abstract][Full Text] [Related]
2. Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.
Ramtvedt BE; Aabech HS; Sundet K
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):130-9. PubMed ID: 24666268
[TBL] [Abstract][Full Text] [Related]
3. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial.
Ramtvedt BE; Sundet K
Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Osland ST; Steeves TD; Pringsheim T
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
[TBL] [Abstract][Full Text] [Related]
5. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
Efron D; Jarman F; Barker M
Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.
Senior HE; McKinlay L; Nikles J; Schluter PJ; Carmont SA; Waugh MC; Epps A; Lloyd O; Mitchell GK
BMC Pediatr; 2013 May; 13():89. PubMed ID: 23710976
[TBL] [Abstract][Full Text] [Related]
8. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2006 Feb; 27(1):1-10. PubMed ID: 16511362
[TBL] [Abstract][Full Text] [Related]
9. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
[TBL] [Abstract][Full Text] [Related]
10. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.
Stevenson RD; Wolraich ML
Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938
[TBL] [Abstract][Full Text] [Related]
11. Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.
Nikles CJ; McKinlay L; Mitchell GK; Carmont SA; Senior HE; Waugh MC; Epps A; Schluter PJ; Lloyd OT
Trials; 2014 Feb; 15():54. PubMed ID: 24524676
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate versus dextroamphetamine in ADHD.
Efron D
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180
[No Abstract] [Full Text] [Related]
13. Medium-term outcomes are comparable with short-term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication.
Efron D; Jarman FC; Barker MJ
J Paediatr Child Health; 2000 Oct; 36(5):457-61. PubMed ID: 11036801
[TBL] [Abstract][Full Text] [Related]
14. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
15. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
16. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; McNairn N; Clavarino A
Eur J Clin Pharmacol; 2007 Nov; 63(11):985-9. PubMed ID: 17701403
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use.
Jain R; Babcock T; Burtea T; Dirks B; Adeyi B; Scheckner B; Lasser R; Renna J; Duncan D
Adv Ther; 2013 May; 30(5):472-86. PubMed ID: 23681505
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial.
Coghill DR; Banaschewski T; Lecendreux M; Zuddas A; Dittmann RW; Otero IH; Civil R; Bloomfield R; Squires LA
Eur Child Adolesc Psychiatry; 2014 Feb; 23(2):61-8. PubMed ID: 23708466
[TBL] [Abstract][Full Text] [Related]
20. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]